Top Eminent Healthcare Group 6877.HK · HKD

Financials · HKEX · 🇭🇰 Hong Kong

Compare

0.09

—

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2025

Net income

−HK$7.1m

FY2016FY2025

Total assets

HK$246.4m

FY2016FY2025

Shareholders' equity

HK$240.7m

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Research and development	—	—	—	HK$0	HK$6	HK$530	HK$11	—	—	—
Operating income	−HK$6.5m	−HK$2.9m	HK$14.6m	−HK$10.8m	−HK$48.7m	−HK$80.6m	−HK$167.1m	HK$80.2m	HK$36.4m	HK$55.4m
Net income	−HK$7.1m	HK$11.3m	HK$9.8m	−HK$31.1m	−HK$56.5m	−HK$71.6m	−HK$180.0m	HK$34.2m	HK$27.4m	HK$38.7m
Diluted earnings per share	-0.00	0.01	0.00	-0.02	-0.03	-0.04	-0.09	0.01	0.01	0.02

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	HK$246.4m	HK$279.4m	HK$251.8m	HK$284.3m	HK$330.6m	HK$430.4m	HK$504.2m	HK$1.14bn	HK$1.40bn	HK$1.08bn
Cash and short-term investments	HK$207.7m	HK$205.2m	HK$222.4m	HK$211.8m	HK$234.5m	HK$289.8m	HK$379.2m	HK$725.0m	HK$517.8m	HK$477.8m
Total liabilities	HK$5.8m	HK$35.1m	HK$11.9m	HK$53.5m	HK$61.9m	HK$97.4m	HK$113.3m	HK$567.5m	HK$853.6m	HK$567.6m
Debt	—	—	HK$1.3m	HK$6.9m	HK$9.6m	HK$10.7m	HK$22.2m	HK$191.3m	HK$252,000	HK$55.9m
Shareholders' equity	HK$240.7m	HK$244.3m	HK$239.9m	HK$230.8m	HK$268.8m	HK$333.1m	HK$391.0m	HK$571.7m	HK$547.2m	HK$514.5m
Shares outstanding	2,033m	2,033m	2,033m	2,033m	2,034m	2,033m	2,033m	2,357m	2,033m	2,033m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Operating income	HK$3.2m	HK$30.2m	−HK$68.7m	HK$25.3m	HK$18.4m	HK$18.4m	HK$15.6m	HK$15.6m
Net income	HK$1.4m	HK$684,500	−HK$4.9m	−HK$2.4m	−HK$1.1m	−HK$1.1m	HK$2.5m	HK$2.5m
Diluted earnings per share	0.00	0.00	-0.00	-0.00	-0.00	-0.00	0.00	0.00
Total assets	HK$275.2m	HK$275.2m	HK$246.4m	HK$246.4m	HK$266.2m	HK$266.2m	HK$279.4m	HK$279.4m
Cash and short-term investments	HK$212.8m	—	HK$207.7m	—	HK$217.4m	—	HK$205.2m	HK$9.4m
Shareholders' equity	HK$242.8m	HK$242.8m	HK$240.7m	HK$240.7m	HK$248.2m	HK$248.2m	HK$244.3m	HK$244.3m

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	41.1%	87.7%	-12.2%
Operating income	-15.3%	-39.5%	—
Net income	-38.8%	-37.0%	—

Average margins

Over each period

	1 year	3 years	5 years	10 years
Operating margin	-4.8%	-1.3%	-30.9%	0.0%
Net margin	2.2%	-4.0%	-33.2%	-6.0%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	-42.0	17.6	14.5	-5.9	-1.6	-2.2	-1.4	8.7	17.6	12.0
Price to sales	2.7	2.3	0.7	4.7	16.5	33.9	18.6	0.7	0.9	1.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 19 May 2015.

	FY2015	FY2014	FY2013
Paid in the year	0.017	0.012	0.007

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Top Eminent Healthcare Group 6877.HK · HKD

Search any instrument

At a glance

Income statement

Balance sheet

Latest quarters

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology